Identification of novel selective antagonists for cyclin C by homology modeling and virtual screening

International Journal of Biological Macromolecules

Volumn 48, Issue 2, 2011, Pages 292-300

  Rajender, P Sarita ^a   Vasavi, M ^a   Vuruputuri, Uma ^a  

^a OSMANIA UNIVERSITY   (India)

Author keywords

ADME; Cyclin C; Cyclin dependent kinase; Homology modeling; Virtual screening

Indexed keywords

CYCLIN C; CYCLIN C INHIBITOR; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BINDING SITE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; COMPUTER PROGRAM; CONTROLLED STUDY; HUMAN; HYDROGEN BOND; MOLECULAR DOCKING; MOLECULAR INTERACTION; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TARGETING; SEQUENCE HOMOLOGY; THREE DIMENSIONAL IMAGING; VALIDATION PROCESS; VIRTUAL SCREENING;

EID: 79551686876     PISSN: 01418130     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2010.11.015     Document Type: Article

References (47)

1. Kirkpatrick P. Structure-based drug design: cycle stopper. Research Highlight. Nat. Rev. Drug Discov. 2002, 1:96-97.
2. Sarita P.R., Ramasree D., Bhargavi K., Vasavi M., Uma V. Selective inhibition of proteins regulating CDK/cyclin complexes: strategy against cancer - a review. J. Recept. Signal Transduct. Res. 2010, 30:206-213.
3. Katona R.L., Lahtl J.M. Cyclin C Genetics and Tumour Cell Biology. UCSD - Nature Molecule Pages [Online] 2006, Available from: http://www.signaling-gateway.org/molecule/afcsid=A000720.
4. Liu Z.J., Ueda T., Miyazaki T., Tanaka N., Mine S., Tanaka Y., Taniguchi T., Yamamura H., Minami Y. A critical role for cyclin C in promotion of the hematopoietic cell cycle by cooperation with c-Myc. Mol. Cell. Biol. 1998, 18:3445-3454.
5. Gold M.O., Tassan J.P., Nigg E.A., Rice A.P., Herrmann C.H. Viral transactivators E1A and VP16 interact with a large complex that is associated with CTD kinase activity and contains CDK8. Nucleic Acids Res. 1996, 24:3771-3777.
6. Rickert P., Seghezzi W., Shanahan F., Cho H., Lees E. Cyclin C/CDK8 is a novel CTD kinase associated with RNA polymerase II. Oncogene 1996, 12:2631-2640.
7. Kang M.E., Dahmus M.E. RNA polymerases IIA and IIO have distinct roles during transcription from the TATA-less murine dihydrofolate reductase promoter. J. Biol. Chem. 1993, 268:25033-25040.
8. Liu Y., Kung C., Fishburn J., Ansari A.Z., Shokat K.M., Hahn S. Two cyclin-dependent kinases promote RNA polymerase II transcription and formation of the Scaffold complex. Mol. Cell. Biol. 2004, 24:1721-1735.
9. Ansari A.Z., Ogirala A., Ptashne M. Transcriptional activating regions target attached substrates to a cyclin-dependent kinase. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:2346-2349.
10. Traven A., Jelicic B., Sopta M. Yeast Gal4: a transcriptional paradigm revisited. EMBO Rep. 2006, 7:496-499.
11. Shiekhattar R., Mermelstein F., Fisher R.P., Drapkin R., Dynlacht B., Wessling H., Morgan D.O., Reinberg D. Cdk activating kinase complex is a component of human transcription factor TFIIH. Nature 1995, 374:283-287.
12. Akoulitchev S., Chuikov S., Reinberg D. TFIIH is negatively regulated by cdk8-containing mediator complexes. Nature 2000, 407:102-106.
13. Hengarther C.J., Myer V.E., Liao S.M., Wilson C.J., Koh S.S., Young R.A. Temporal regulation of RNA polymerase II by Srb 10 and Kin 28 cyclin dependent kinases. Mol. Cell 1998, 2:43-53.
14. Ren S., Rollins B.J. Cyclin C/cdk3 promotes Rb-dependent G0 exit. Cell 2004, 117:239-251.
15. Tomashevski1 A., Webster D.R., Grammas P., Gorospe M., Kruman I.I. Cyclin-C-dependent cell-cycle entry is required for activation of non-homologous end joining DNA repair in postmitotic neurons. Cell Death Differ. 2010, 17:1189-1198.
16. Sage J. Cyclin C makes an entry into the cell cycle. Dev. Cell. 2004, 6:607-608.
17. Tassan J.P., Jaquenoud M., Leopold P., Schultz S.J., Nigg E.A. Identification of human cyclin-dependent kinase 8, a putative protein kinase partner for cyclin C. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:8871-8875.
18. Bishop A.O.T., de Beer A.P.T., Joubert F. Protein homology modelling and its use in South Africa. S. Afr. J. Sci. 2008, 104:1-2.
19. Vasavi M., Bargavi G., Bhargavi K., Ramasree D., Uma V. Study of interactions between Mycobacterium tuberculosis proteins: SigK and anti-SigK. J. Mol. Model. 2010, 10.1007/s00894-010-0792-7.
20. Juretic D., Zoranic L., Zucic D. Basic charge clusters and predictions of membrane protein topology. J. Chem. Inf. Comput. Sci. 2002, 42:620-632.
21. T.G. Wolfsberg, L.T. Madden, Sequence similarity searching using the BLAST family of programs. Current Protocols in Protein Science. UNIT 2.5. doi:10.1002/0471140864.ps0205s15.
22. Christian C., Jonathan D.B., Geoffrey J.B. The Jpred 3 secondary structure prediction server. Nucleic Acids Res. 2008, 36:197-201.
23. Kelley L.A., Sternberg M.J.E. Protein structure prediction on the web: a case study using the Phyre server. Nat. Protoc. 2009, 4:363-371.
24. Thompson D.J., Higgins D.G., Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994, 22:4673-4680.
25. Sali A., Pottertone L., Yuan F., Van V.H., Karplus M. Evaluation of comparative protein modeling by MODELLER. Proteins 1995, 233:18-326.
26. Fiser A., Giando R.K., Šali A. Modeling of loops in protein structures. Prot. Sci. 2000, 9:1753-1773.
27. Guex N., Peitsch M.C. SWISS-MODEL and the Swiss-Pdb viewer: an environment for comparative protein modeling. Electrophoresis 1997, 18:14-23.
28. Salam N.K., Nuti R., Sherman W. Novel method for generating structure-based pharmacophores using energetic analysis. J. Chem. Inf. Model. 2009, 49:2356-2368.
29. Laskowski R.A., Rullmannn J.A., MacArthur M.W., Kaptein R., Thornton J.M. AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J. Biomol. NMR 1996, 8:477-486.
30. Laskowsky R.A., MacArthur M.W., Moss D.S., Thornton J.M. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 1993, 26:283-291.
31. Sippl M.J. An efficient potential protein sequence design. Proteins 1993, 17:355-362.
32. Brindha V., Saravanan A., Manimekalai R. Drug designing for ring finger protein 110 involved in adenocarcinoma (human breast cancer) using casuarinin extracted from Terminalia arjuna. Ind. J. Sci. Technol. 2009, 2:22-26.
33. Dundas J., Ouyang Z., Tseng J., Binkowski A., Turpaz Y., Liang J. CASTp: computed atlas of surface topography of proteins with structural and topographical mapping of functionally annotated residues. Nucleic Acids Res. 2006, 34:116-118.
34. Laurie A.T., Jackson R.M. Q-SiteFinder: an energy-based method for the prediction of protein-ligand binding sites. Bioinformatics 2005, 21:1908-1916.
35. Site map, Schrödinger, Inc., 120 West 45th Street, 29th Floor, New York, NY 10036.
36. Hoeppner S., Baumli S., Cramer P. Structure of the mediator subunit cyclin C and its implications for CDK8 function. J. Mol. Biol. 2005, 350:833-842.
37. Schrodinger, Inc. 120 West 45th Street, 32nd floor, New York, NY 10036-4041, US.
38. Kawatkar S., Wang H., Czerminski R., McCarthy D.J. Virtual fragment screening: an exploration of various docking and scoring protocols for fragments using glide. J. Comput. Aided Mol. Des. 2009, 23:527-539.
39. Louise-May S., Yang W., Nie X., Liu D., Deshpande M.S., Phadke A.S., Huang M., Agarwal A. Discovery of novel dialkyl substituted thiophene inhibitors of HCV by in silico screening of the NS5B RdRp. Biol. Med. Chem. Lett. 2007, 17:3905-3909.
40. Stahl M., Guba W., Kansy M. Integrating molecular design resources within modern drug discovery research: the Roche experience. Drug Discov. Today 2006, 11:326-333.
41. Friesner R.A., Banks J.L., Murphy R.B., Halgren T.A., Klicic J.J., Mainz D.T., Repasky M.P., Knoll E.H., Shelley M., Perry J.K., Shaw D.E., Francis P., Shenkin P.S. Glide: a new approach for rapid, accurate docking and scoring. Method and assessment of docking accuracy. J. Med. Chem. 2004, 47:1739-1749.
42. Friesner R.A., Murphy R.B., Repasky M.P., Frye L.L., Greenwood J.R., Halgren A.T., Sanschagrin C.P., Mainz D.T. Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J. Med. Chem. 2006, 49:6177-6196.
43. QikProp Version 2.3 2005, Schrödinger, LLC, New York, NY.
44. Gerard J.K., Jones T.A. Phi/Psi-chology: Ramachandran revisited. Structure 1996, 4:1395-1400.
45. Wiederstein M., Sippl M.J. ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res. 2007, 35. (Web Server issue W407-410). 10.1093/nar/gkm290.
46. Burba A.E.C., Lehnert U., Eric Z.Yu., Gerstein M. Structural bioinformatics: helix interaction tool (HIT): a web-based tool for analysis of helix-helix interactions in proteins. Bioinformatics 2006, 22:2735-2738. 10.1093/bioinformatics/btl274.
47. Agostino M., Jene C., Boyle T., Ramsland P.A., Yuriev E. Molecular docking of carbohydrate ligands to antibodies: structural validation against crystal structures. J. Chem. Inf. Model. 2009, 49:2749-2760.